Michael Bergman, Melania Manco, Ilhan Satman, Juliana Chan, Maria Inês Schmidt, Giorgio Sesti, Teresa Vanessa Fiorentino, Muhammad Abdul-Ghani, Ram Jagannathan, Pramod Kumar Thyparambil Aravindakshan, Rafael Gabriel, Viswanathan Mohan, Martin Buysschaert, Abdullah Bennakhi, Andre Pascal Kengne, Brenda Dorcely, Peter M Nilsson, Tiinamaija Tuomi, Tadej Battelino, Akhtar Hussain, Antonio Ceriello, Jaakko Tuomilehto
Many individuals with intermediate hyperglycaemia (IH), including impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT), as presently defined, will progress to type 2 diabetes (T2D). There is confirmatory evidence that T2D can be prevented by lifestyle modification and/or medications, in people with IGT diagnosed by 2-h plasma glucose (PG) during a 75-gram oral glucose tolerance test (OGTT). Over the last 40 years, a wealth of epidemiological data has confirmed the superior value of 1-h plasma glucose (PG) over fasting PG (FPG), glycated haemoglobin (HbA1c ) and 2-h PG in populations of different ethnicity, sex and age in predicting diabetes and associated complications including death...
March 6, 2024: Diabetes Research and Clinical Practice